Latest filing published 29 Jun 2026 for Abbott Laboratories.
Filing timeline
BuySaleInsider track record
Elizabeth C. Cushman: trading record in brief
Elizabeth C. Cushman discloses dealings in Abbott Laboratories to SEC (Form 4). Between 27 June 2025 and 27 June 2026, the trades on record add up to 5 filings.
No open-market purchase appears, only 1 sale worth €26k. Other entries cover 4 share grants. So far in 2026, the count stands at no purchases and 1 sale.
The newest entry dates from 29 June 2026: a share grant, in Abbott Laboratories. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Elizabeth C. Cushman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 560 sharesCommon shares without par valueSEC:0002075371-26-000009:0
- 1,421 shares@ US$116.2684.4% of flowCommon shares without par valueSEC:0002075371-26-000007:0
- 263 shares@ US$115.5815.6% of flowCommon shares without par valueSEC:0002075371-26-000007:1
- 15,031 shares0Common shares without par valueSEC:0002075371-26-000002:0
- 3,790 shares0Common shares without par valueSEC:0001415889-25-018721:0
5 of 5 declarations
